08:58 AM EST, 11/10/2025 (MT Newswires) -- AN2 Therapeutics ( ANTX ) said Monday the company has signed a collaboration agreement with GSK (GSK) to develop new therapies for tuberculosis.
Financial details of the collaboration agreement weren't disclosed.
Shares of AN2 Therapeutics ( ANTX ) were up over 1% in recent Monday premarket activity.